Revel Pharmaceuticals
CA - San FranciscoPharmaceutical
Focus: Revel Pharmaceuticals is a newly founded (2024) company focused on therapeutic enzymes with initial concentration in neurology. The company is in pre-commercial stage with no disclosed products or pipeline programs.
Profile data last refreshed 3h ago · AI intelligence enriched 1mo ago
Open Jobs
1+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Revel Pharmaceuticals?
AI assessmentRevel is a speculative early-stage opportunity suitable only for founders-minded scientists and operators comfortable with significant uncertainty and no near-term product catalysts.
Why Work Here
- Ground-floor opportunity at a 2024-founded company focused on emerging therapeutic enzyme modality in neurology
- Potential to shape company culture, science direction, and team structure from inception
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Interview Prep Quick Facts
Help build intelligence for Revel Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.